In a surprising twist, President Trump hints at tariff exemptions for certain electronic products from China. As tensions rise, will this signal a change in strategy or is it just a temporary pause?
President Trump announces significant tariffs on pharmaceutical imports to revive U.S. manufacturing. Will this bold move shake the global drug market and impact upcoming midterms?
In a dramatic response to escalating US trade tariffs, New Zealand cuts interest rates, raising concerns about a global recession. Markets across Asia tumble as Trump's new tariffs take effect. Discover the potential fallout and what it means for economies worldwide.
In a surprising turn, Indian drugmakers' shares jumped 5% following the U.S. exempting pharmaceuticals from new tariffs. This decision could significantly boost India's pharma exports, which reached $9 billion last year.
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
President Trump is set to announce new tariffs on automobiles and pharmaceuticals soon, adding to his ongoing trade war strategy that includes steel and aluminum duties. This move signals a broader effort to reshape U.S. trade policies as April 2 approaches.
Eli Lilly is set to unveil results from trials of orforglipron, its groundbreaking once-daily obesity pill, potentially revolutionizing weight loss treatment by offering a needle-free alternative. Analysts predict it could capture a significant share of the $150 billion GLP-1 market.
As President Trump prepares for his April 2 'Liberation Day' announcement, speculation rises over the exclusion of sector-specific tariffs. With a focus on the 'Dirty 15' countries, how will these changes impact the U.S. economy and global trade?
Eli Lilly to invest $27 billion in building new US manufacturing plants amid challenges from drug import duties. The move aligns with Trump's push for American manufacturing revitalization.
Discover how Eli Lilly's $50 billion investment in US manufacturing will create high-wage jobs, advance pharmaceutical innovation, and boost economic growth.
